Topics

Phase 3C – Market Approval and the Soft Launch

For years we have followed the logical progression of products through clinical trials and ...

Industry Briefs

POLLSTERS MERGE Survey Sampling International (SSI) and Opinionology announced that they have received regulatory ...

Healthcare Highlights

ONE PILL. MULTIPLE DRUGS. Pharma companies should start thinking about which of their drugs ...

Strategic Priorities for Specialty Care Products

By 2013, specialty drugs will account for half of all pharmaceutical spending…and most of ...

Turning Competitive Intelligence Into a Winning Strategy

The emergence of social media, evolving prescriber information demands, and new data sources makes ...

The Paradigm Shift in Key-Opinion-Leader Marketing: A Brief

Expanded reporting requirements, especially the Sunshine Act, will accelerate the migration away from product-driven ...

Serving Up What the Doctor Ordered-Effectively!

We have spent many of the last columns discussing the use of multichannel marketing ...

DTC’s Talent Drain

According to IMS, patent expirations will reduce brand spending on prescription drugs by $120 ...

Cutting Edge

What’s not to love about the latest technology and the hottest trendy products? Our ...

Help Yourself, Help Your Kids

If you don’t know Judy Zerafa, you should. She is a latter day Napoleon ...